510(k) Report

510(k) · Cleared

Cleared

ON Call Vivid Blood Glucose Monitoring Systems

K112653510(k) TraditionalCleared Apr 9, 2012210-day reviewClass I21 CFR 862.1660

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

ACON Laboratories, Inc. · JJX Single (Specified) Analyte Controls (Assayed And Unassayed)

Cleared on Apr 9, 2012 as substantially equivalent to K002134 (Selfcare, Inc., 2000) after a 210-day review. Its family tree reaches back 1 generation to 2000. 7 later devices descend from it.

Decided
Apr 9, 2012
Review
210 days
Class
Class I
Product code
JJX
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K002134 (2000). 7 later devices descend from it, 3 citing it directly.

Descendants, by year cleared 2014: 1 descendant cleared2013: 2 descendants cleared2018: 1 descendant cleared2020: 2 descendants cleared2015: 1 descendant clearedK002134 · One Touch Ultra Blood Glucose Monitoring System · Selfcare, Inc. · 2000200020052010201520202025
Descendants, by generation 1 generation forward: 3 descendants2 generations forward: 3 descendants3 generations forward: 1 descendant K002134 · One Touch Ultra Blood Glucose Monitoring System · Selfcare, Inc. · 20000
  1. Root · 1 generation backK002134 One Touch Ultra Blood Glucose Monitoring SystemSelfcare, Inc. · 2000
  2. This deviceK112653 ON Call Vivid Blood Glucose Monitoring SystemsACON Laboratories, Inc. · 2012
  3. Descendant · cites it directly · 3 of its ownK130284 ON Call Sharp Blood Glucose Monitoring SystemACON Laboratories, Inc. · 2013
  4. Descendant · 2 generations on · 1 of its ownK181527 On Call Sure Blood Glucose Monitoring System, On Call Sure Sync…ACON Laboratories, Inc. · 2018
  5. Descendant · cites it directly · 1 of its ownK132086 ON Call Express Blood Glucose Monitoring SystemACON Laboratories, Inc. · 2013
  6. Descendant · 2 generations on · 0 of its ownK193340 GoChek Blood Glucose Monitoring System, GoChek Connect Blood Glucose…Microtech Medical, Inc. · 2020
  7. Descendant · 3 generations on · 0 of its ownK200277 Livongo Blood Glucose Monitoring System (BG1000)Livongo Health, Inc. · 2020

Showing 5 of 7 descendants. See all descendants

Descendants cleared per year

2013: 22014: 12015: 12018: 12020: 2
2013high 2 (2013) · low 0 (2016)2026

Most influential descendants

Showing 5 of 7 · See all
  • K130284ON Call Sharp Blood Glucose Monitoring SystemACON Laboratories, Inc. · 2013 · cites it directly3descendants
  • K181527On Call Sure Blood Glucose Monitoring System, On Call Sure Sync Blood Glucose Monitoring…ACON Laboratories, Inc. · 2018 · 2 generations on1descendant
  • K132086ON Call Express Blood Glucose Monitoring SystemACON Laboratories, Inc. · 2013 · cites it directly1descendant
  • K193340GoChek Blood Glucose Monitoring System, GoChek Connect Blood Glucose Monitoring SystemMicrotech Medical, Inc. · 2020 · 2 generations on0descendants
  • K200277Livongo Blood Glucose Monitoring System (BG1000)Livongo Health, Inc. · 2020 · 3 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K002134One Touch Ultra Blood Glucose Monitoring SystemSelfcare, Inc.2000—
0 (this device)K112653ON Call Vivid Blood Glucose Monitoring SystemsACON Laboratories, Inc.2012—
+1K130284ON Call Sharp Blood Glucose Monitoring SystemACON Laboratories, Inc.2013—
+2K181527On Call Sure Blood Glucose Monitoring System, On Call Sure Sync Blood Glucose…ACON Laboratories, Inc.2018—
+1K132086ON Call Express Blood Glucose Monitoring SystemACON Laboratories, Inc.2013—
+2K193340GoChek Blood Glucose Monitoring System, GoChek Connect Blood Glucose…Microtech Medical, Inc.2020—
+3K200277Livongo Blood Glucose Monitoring System (BG1000)Livongo Health, Inc.2020—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201320
201410
201510
201810
202020
FIG. 1 — Lineage of K112653, 2000–2020Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JJX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K002134One Touch Ultra Blood Glucose Monitoring System
Summary page 1
…tem Predicate Device: One Touch Ultra Blood Glucose Monitoring System Lifescan, Inc., located at 1000 Gibraltar Dr., Milpitas, CA 95035, USA. 510(k) Number: K002 134 2 Device Name: On Call Vivid Blood Glucose Monitoring Syste…
Selfcare, Inc.2000—

Also cleared against K002134: 9 other devices →

What descends from it? (7)

3 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K130284ON Call Sharp Blood Glucose Monitoring SystemACON Laboratories, Inc.20133
K132086ON Call Express Blood Glucose Monitoring SystemACON Laboratories, Inc.20131
K133584IN Touch Blood Glucose Monitoring SystemEoshealth, Inc.20140

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • Of its descendants, K130284 (ACON Laboratories, Inc., 2013) has gone furthest, with 3 descendants of its own.
  • 9 other devices also cite its predicate K002134.

How does its category compare?

All JJX devices

JJX Single (Specified) Analyte Controls (Assayed And Unassayed): FDA decisions, review times, recalls and adverse event reports over 20 years. 2012, this device’s year, is highlighted.

FDA decisions per year · JJX

2in 2017

2007: 62008: 82009: 172010: 242011: 192012: 152013: 192014: 222015: 112016: 62017: 2
2007high 24 (2010) · low 0 (2018)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JJX

31in 2016

2007: 53 days median2008: 52 days median2009: 80 days median2010: 80 days median2011: 62 days median2012: 40 days median2013: 37 days median2014: 30 days median2015: 65 days median2016: 31 days median
2007high 80 (2009) · low 30 (2014)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · JJX

1in 2021

2007: 32008: 32010: 32011: 22014: 12015: 12016: 22018: 22021: 1
2007high 3 (2007) · low 0 (2009)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JJX

22in 2025

2007: 22009: 12010: 62011: 622012: 322013: 512014: 482015: 672016: 372017: 192018: 352019: 822020: 772021: 432022: 242023: 222024: 302025: 22
2007high 82 (2019) · low 0 (2008)2025

MAUDE reports naming product code JJX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200765332
200885230
2009178001
2010248036
20111962262
20121540032
20131937051
20142230148
20151165167
2016631237
20172—019
20180—235
20190—082
20200—077
20210—143
20220—024
20230—022
20240—030
20250—022
20260—0—

What is it indicated for?

The On Call® Vivid Blood Glucose Monitoring System is an electrochemical enzymatic assay for the quantitative detection of glucose in fresh capillary whole blood from the fingertip, forearm, and palm by people with diabetes at home as an aid in monitoring the effectiveness of diabetes control programs. Alternate testing sites (forearm and palm) should be used only during steady-state times (when blood glucose level is not changing rapidly). The On Call®)…

Read the full statement (207 words)

The On Call® Vivid Blood Glucose Monitoring System is an electrochemical enzymatic assay for the quantitative detection of glucose in fresh capillary whole blood from the fingertip, forearm, and palm by people with diabetes at home as an aid in monitoring the effectiveness of diabetes control programs. Alternate testing sites (forearm and palm) should be used only during steady-state times (when blood glucose level is not changing rapidly). The On Call®) Vivid Blood Glucose Monitoring System is intended to be used by a single patient and should not be used for testing multiple patients. It is for in vitro diagnostic use only.

The On Call® Vivid Blood Glucose Monitoring System should not be used for the diagnosis of or screening for diabetes mellitus or for neonatal use.

The On Call® Vivid Blood Glucose Test Strips are used with the On Call Vivid Blood Glucose Meter in the quantitative measurement of glucose in fresh capillary blood from the fingertip, forearm, and palm.

The On Call® Vivid Blood Glucose Control Solution is for use with the On Call® Vivid Blood Glucose Meter and Test Strips as a quality control check to verify that the meter and test strips are working together properly and that the test is performing correctly.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K112653: ON Call Vivid Blood Glucose Monitoring Systems.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K112653

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026